SCP Investment’s Merck MRK Stock Holding History

SCP Investment’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-41,920	Closed	-$2.43M	–	49
2018 Q2	$2.43M	Hold	41,920	–	–	1.2%	30
2018 Q1	$2.18M	Sell	41,920 -22,301	-35%	-$1.2M	1.44%	25
2017 Q4	$3.45M	Buy	+64,221	New	+$3.56M	3.57%	8

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SCP Investment's MRK Position: Q3 2018 in Review

SCP Investment sold out of Merck (MRK) in Q3 2018, closing a stake of 41,920 shares — an estimated $2.43M sold.

SCP Investment first reported a position in MRK in Q4 2017 and held it in 3 quarters. The position peaked at $3.45M in Q4 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

SCP Investment reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
SCP Investment sold 41,920 Merck shares in Q3 2018, an estimated $2.43M.
SCP Investment first reported a position in Merck in Q4 2017 and held it in 3 quarters.
SCP Investment's Merck position peaked at $3.45M in Q4 2017.
2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on SCP Investment's 13F filing for Q3 2018, filed 13 Nov 2018.